Icon Bioscience, Inc., Sunnyvale, California  Icon Bioscience, Inc., Sunnyvale, California
 Icon Bioscience, Inc.

 

 
 
Verisome®Technology

 




At the core of IBI's product line is the unique and flexible Verisome® platform. The Verisome® technology is a novel drug delivery system with very broad topical, systemic and ocular applications.  The ocular Verisome® products are uniquely positioned to treat ophthalmic diseases as they can be administered by injection and slowly deliver the drug as the Verisome® system simultaneously degrades.  Delivery duration up to a year with a standard intravitreal injection has been demonstrated in human clinical trials.      

The Verisome® drug delivery technology is the most advanced, yet simplest, system for controlling the release of therapeutic agents in the eye for extended periods of time.  The Verisome® technology’s versatility can support a wide range of products individually formulated to meet the requirements of a given active agent and the demands of a specific clinical situation.